The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence
Patients with chronic liver diseases (CLD) undergo a range of invasive procedures during their clinical lifetime. Various hemostatic abnormalities are frequently identified during the periprocedural work-up; including thrombocytopenia. Thrombocytopenia of cirrhosis is multifactorial in origin, and d...
Saved in:
Main Authors: | Kamran Qureshi, Shyam Patel, Andrew Meillier |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2016/1802932 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
by: T. A. Deeva, et al.
Published: (2025-02-01) -
Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
by: Paschalis Evangelidis, et al.
Published: (2025-01-01) -
Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia
by: Ke Zhang, et al.
Published: (2018-01-01) -
Letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”
by: Matthew K. Wun
Published: (2025-01-01) -
Response to letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”
by: Marjory B. Brooks, et al.
Published: (2025-01-01)